Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2025-08-11 00:00:00 ET · period of report 2025-08-07 · accession 0001765581-25-000074 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-11 | 2025-08-07 | JAZZ | GALA RENEE D | Pres, CEO | A - Grant | $0.00 | +18.8K | 107.9K | +21% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-08-07 | A | A | 18,808 | $0.00 | 107,869 | D | — | — | (F2) The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 30, 2025. |